Skip to main content

Odactra News

U.S. FDA Approves ALK's Odactra (House Dust Mite Allergen Extract) Tablet for Sublingual Use as Immunotherapy for Adolescents

Odactra is now indicated to treat house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis, in persons 12 through 17 years of age, in addition to adults 18 through 65 years of...

FDA Approves Odactra for House Dust Mite Allergies

March 1, 2017 – The U.S. Food and Drug Administration today approved Odactra, the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite (HDM)-induced...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Hay Fever, Allergic Rhinitis

Odactra patient information at Drugs.com